ClinicalTrials.Veeva

Menu
D

D&H National Research Centers | Miami, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Cenerimod
Dexlansoprazole
Methotrexate
EDP-235
SAB-185
Dulaglutide
MTX
LY2189265
LPCN 1154A
Ridinilazole

Parent organization

This site is a part of D&H National Research Centers

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

11 of 37 total trials
New

A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout

The primary objective of this trial is to evaluate the effect of pegloticase 18 mg subcutaneously (SC) every two weeks with methotrexate (MTX) versus...

Enrolling
Uncontrolled Gout
Drug: Pegloticase
Drug: Methotrexate

This Phase 3 study is conducted to evaluate lanifibranor in adults with NASH and liver fibrosis histological stage F2 or F3

Enrolling
NASH - Nonalcoholic Steatohepatitis
Drug: Placebo
Drug: IVA337

The goal of this clinical trial is to see how well cenerimod reduces symptoms of Systemic Lupus Erythematous in adult patients with moderate to sever...

Enrolling
Lupus Erythematosus, Systemic
Drug: Cenerimod
Drug: Placebo
Locations recently updated

The purpose of this clinical study is to look into how well a study medicine called CagriSema helps children and adolescents living with diabetes low...

Begins enrollment in 5 months
Diabetes Mellitus, Type 2
Drug: CagriSema (Cagrilintide B and Semaglutide I)
Drug: Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)

The main purpose of this study is to evaluate additional dosing options for dulaglutide in pediatric participants with Type 2 Diabetes. Participation...

Enrolling
Type 2 Diabetes
Drug: Dulaglutide

The purpose of this research study is to test the study drug, LPCN 1154A, as a possible treatment for postpartum depression (PPD). The trial aims to...

Enrolling
Depression, Post-Partum
Depression, Postpartum
Drug: Placebo
Drug: LPCN 1154A

Gastroesophageal reflux disease (GERD) is caused by food or acid coming up from the stomach into the esophagus, repeatedly. The esophagus is the tube...

Enrolling
Erosive Esophagitis
Drug: Dexlansoprazole

Gastroesophageal reflux disease (GERD) is caused by food or acid coming up from the stomach into the esophagus, repeatedly. The esophagus is the tube...

Enrolling
Gastroesophageal Reflux Disease (GERD)
Drug: Dexlansoprazole

The study consists of 24-week double-blind trial to evaluate the non-inferiority of the efficacy and safety of pegloticase Q4W with MTX versus peglot...

Active, not recruiting
Gout
Drug: Methotrexate
Biological: Pegloticase

This study assesses the efficacy, safety, and pharmacokinetics of multiple-dose oral administration of daridorexant in pediatric subjects aged 10 to...

Active, not recruiting
Insomnia
Drug: Daridorexant 10 mg
Drug: Daridorexant 25 mg

The goal of this clinical study is to learn about the long-term safety and tolerability of cenerimod in adult patients with moderate to severe sympto...

Invitation-only
Lupus Erythematosus, Systemic
Drug: Cenerimod

Trial sponsors

Amgen logo
V
Takeda logo
Thermo Fisher Scientific logo
A
AbbVie logo
Abbott logo
A
Enanta Pharmaceuticals logo
E

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems